Mylan offers discounts on EpiPen after wave of criticism
Staff Writer |
Mylan said it is taking immediate action to further enhance access to EpiPen Auto-Injector by expanding already existing programs.
Article continues below
Mylan is reducing the patient cost of EpiPen Auto-Injector through the use of a savings card which will cover up to $300 for their EpiPen 2-Pak.
For patients who were previously paying the full amount of the company's list price for EpiPen, this effectively reduces their out-of-pocket cost exposure by 50%.
Mylan also is doubling the eligibility for its patient assistance program, which will eliminate out-of-pocket costs for uninsured and under-insured patients and families as well.
Mylan has worked to help patients with commercial insurance pay as little as $0 for EpiPen Auto-Injector using the My EpiPen Savings Card. In 2015, this resulted in nearly 80% of these patients paying nothing out of pocket for their EpiPen Auto-Injector.
However, as the health insurance environment has evolved, driven by the implementation of the Affordable Care Act, patients and families enrolled in high deductible health insurance plans, who are uninsured, or who pay cash at the pharmacy, have faced higher costs for their medicine.
Mylan is taking the immediate actions to help further address the needs of patients and families.
For patients in health plans who face higher out-of-pocket costs, the company is providing immediate relief by offering a savings card for up to $300.
This will effectively reduce by 50% the cost exposure for patients who would have otherwise paid the full list price for EpiPen Auto-Injector.
Mylan also is doubling eligibility for our patient assistance program to 400% of the federal poverty level. This means a family of four making up to $97,200 would pay nothing out of pocket for their EpiPen Auto-Injector.
Further, Mylan will continue to offer the EpiPen4Schools program. The program, launched in August 2012, has provided more than 700,000 free epinephrine auto-injectors and educational resources to more than 65,000 schools nationwide to help them be prepared for anaphylaxis events among students.
Mylan also is opening a pathway so that patients can order EpiPen Auto-Injector directly from the company, thereby reducing the cost.
These programs will apply to EpiPen and EpiPen Jr Auto-Injectors. ■
The European Medicines Agency has issued a positive opinion for the approval of a vaccine named Biobhyo, indicated to protect pigs from swine dysentery, a disease that causes dysenteric diarrhoea in pigs.